BYSI BeyondSpring Inc.
Nasdaq · SEC CIK 1677940 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $564.4K 6 sales by 4 insiders
- Filings on record
- 34 since 2025-04-23, latest 2026-07-06 13:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Decheng Capital Global Healthcare GP, LLC | 10% | — | $283.9K |
| Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | — | $227.7K |
| Decheng Capital Management III (Cayman), LLC | 10% | — | $39.0K |
| Cui Xiangmin | 10% | — | $13.8K |
| Huang Lan | CEO, Dir, 10% | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-15 16:13 | 2026-03-20 | BYSI | Huang Lan | CEO, Dir, 10% | G - Gift | $0.00 | -260.6K | 0 | -100% | $0 |
| MI | 2025-10-20 | 2025-10-16+ | BYSI | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.73 | -131.3K | 1.56M | -8% | -$227.7K |
| MI | 2025-10-15 | 2025-10-13+ | BYSI | Decheng Capital Global Healthcare GP, LLC | 10% | S - Sale | $1.68 | -153.8K | 1.67M | -8% | -$259.2K |
| MI | 2025-10-10 | 2025-10-08+ | BYSI | Decheng Capital Global Healthcare GP, LLC | 10% | S - Sale | $1.78 | -13.9K | 1.81M | -0.8% | -$24.7K |
| MI | 2025-10-07 | 2025-10-03+ | BYSI | Decheng Capital Management III (Cayman), LLC | 10% | S - Sale | $1.78 | -20.2K | 1.82M | -1% | -$36.0K |
| MI | 2025-10-02 | 2025-09-30+ | BYSI | Cui Xiangmin | 10% | S - Sale | $1.80 | -7,665 | 1.84M | -0.4% | -$13.8K |
| MI | 2025-09-29 | 2025-09-25+ | BYSI | Decheng Capital Management III (Cayman), LLC | 10% | S - Sale | $1.69 | -1,800 | 1.85M | -0.1% | -$3,045 |
| MI | 2025-09-24 | 2025-09-22+ | BYSI | Decheng Capital Global Healthcare GP, LLC | 10% | S - Sale | $1.76 | -11.8K | 1.85M | -0.6% | -$20.8K |
| MI | 2025-09-19 | 2025-09-17+ | BYSI | Decheng Capital Global Healthcare GP, LLC | 10% | S - Sale | $1.77 | -11.3K | 1.86M | -0.6% | -$20.0K |
| MI | 2025-09-16 | 2025-09-12+ | BYSI | Decheng Capital Global Healthcare Fund (Master), LP | 10% | S - Sale | $1.85 | -4,110 | 1.87M | -0.2% | -$7,603 |
| MI | 2025-09-11 | 2025-09-09+ | BYSI | Decheng Capital Management III (Cayman), LLC | 10% | S - Sale | $1.94 | -21.0K | 1.87M | -1% | -$40.9K |
| MI | 2025-09-08 | 2025-09-04+ | BYSI | Decheng Capital Management III (Cayman), LLC | 10% | S - Sale | $1.91 | -8,999 | 1.90M | -0.5% | -$17.2K |
| MI | 2025-09-03 | 2025-08-29+ | BYSI | Cui Xiangmin | 10% | S - Sale | $1.78 | -4,870 | 1.90M | -0.3% | -$8,675 |
| MI | 2025-08-28 | 2025-08-26+ | BYSI | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.79 | -4,109 | 1.91M | -0.2% | -$7,358 |
| MI | 2025-08-25 | 2025-08-21+ | BYSI | Decheng Capital Global Healthcare Fund (Master), LP | 10% | S - Sale | $1.77 | -5,710 | 1.92M | -0.3% | -$10.1K |
| MI | 2025-08-20 | 2025-08-18+ | BYSI | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | S - Sale | $1.99 | -54.7K | 1.92M | -3% | -$109.2K |
| MI | 2025-08-15 | 2025-08-14+ | BYSI | Cui Xiangmin | 10% | S - Sale | $2.00 | -4,900 | 1.97M | -0.2% | -$9,800 |
| MI | 2025-08-11 | 2025-06-17+ | BYSI | Cui Xiangmin | 10% | S - Sale | $3.05 | -394.4K | 934.1K | -30% | -$1.20M |
Purchase Sale Sale after option exercise All abbreviations